Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy: a shift in paradigm.

M F L Meijs1, L J de Windt, N de Jonge

  • 1Heart Lung Center Utrecht, Utrecht, The Netherlands.

Current Medicinal Chemistry
|February 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental impact of brine from desalination plants on marine benthic diatom diversity.

Marine environmental research·2025
Same author

eDNA metabarcoding of marine invertebrate communities at RO desalination plant outfalls in Cyprus.

Marine pollution bulletin·2025
Same author

Integrated biological system for remediation and valorization of tannery wastewater: Focus on microbial communities responsible for methanogenesis and sulfidogenesis.

Bioresource technology·2024
Same author

High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial.

Kidney international reports·2023
Same author

Rationale and design of the iCORONARY trial: improving the cost-effectiveness of coronary artery disease diagnosis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2023
Same author

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
Same journal

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Current medicinal chemistry·2026
Same journal

DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

Synthetic AtMP2 from Anabas testudineus: Comprehensive ADMET and In Vivo Toxicity Assessment to Enable Future Therapeutic Development.

Current medicinal chemistry·2026
Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026
See all related articles

Left ventricular hypertrophy (LVH) is a risk factor for heart failure. Blunting the hypertrophic response in animal models preserved cardiac function and improved survival, challenging traditional concepts.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Translational Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a recognized risk factor for heart failure (HF), coronary heart disease, and stroke.
  • Traditionally, LVH is viewed as an adaptive response to hemodynamic overload that can progress to maladaptive hypertrophy and HF.

Purpose of the Study:

  • To investigate the role of the hypertrophic response in cardiac disease progression.
  • To challenge the classical concept of LVH as a solely adaptive mechanism.

Main Methods:

  • Utilized animal models of pressure-overload and myocardial infarction.
  • Assessed the impact of blunting the hypertrophic response on cardiac function and survival.

Main Results:

Related Experiment Videos

  • Blunting the hypertrophic response in animal models was associated with preserved cardiac function.
  • Reduced hypertrophy led to improved survival rates in experimental models.

    • Conclusions:

    • The findings challenge the traditional view of LVH as a beneficial adaptive response.
    • Inhibiting hypertrophy may offer a novel therapeutic strategy for preventing or treating heart failure and related cardiovascular events.